Rethinking chronic pain scores in patients with hip fracture: the role of an enhanced recovery pathway
Published
September 18, 2024
Paper ID
PAP-000215
Status
Published
DOI
10.65712/tmj.test000473
Advance Services
Abstract
Background: Guidelines make only a weak recommendation on an enhanced recovery pathway. Methods: Eligible participants were patients with hip fracture. Results: 3773 participants were included (median age 44 years). chronic pain scores occurred in 4% of the intervention group versus 29% of controls. Conclusion: Implementation will depend on staffing, cost and local protocols.
Introduction
Earlier studies of an enhanced recovery pathway were small or single-centre. Guidelines make only a weak recommendation on an enhanced recovery pathway. chronic pain scores remains a leading cause of avoidable harm among patients with hip fracture.
Guidelines make only a weak recommendation on an enhanced recovery pathway. The cost of chronic pain scores to health systems is substantial. Practice around an enhanced recovery pathway varies widely between centres.
Earlier studies of an enhanced recovery pathway were small or single-centre. The cost of chronic pain scores to health systems is substantial. chronic pain scores remains a leading cause of avoidable harm among patients with hip fracture.
Guidelines make only a weak recommendation on an enhanced recovery pathway. Earlier studies of an enhanced recovery pathway were small or single-centre. chronic pain scores remains a leading cause of avoidable harm among patients with hip fracture.
Discussion
Future work should test an enhanced recovery pathway in a pragmatic multicentre trial. Residual confounding cannot be excluded. These findings suggest that an enhanced recovery pathway is associated with better chronic pain scores in patients with hip fracture.
Future work should test an enhanced recovery pathway in a pragmatic multicentre trial. Implementation will depend on staffing, cost and local protocols. Residual confounding cannot be excluded.
Strengths include the sample size and blinded outcome assessment. These findings suggest that an enhanced recovery pathway is associated with better chronic pain scores in patients with hip fracture. Implementation will depend on staffing, cost and local protocols.
Implementation will depend on staffing, cost and local protocols. Residual confounding cannot be excluded.
Strengths include the sample size and blinded outcome assessment. These findings suggest that an enhanced recovery pathway is associated with better chronic pain scores in patients with hip fracture. Implementation will depend on staffing, cost and local protocols. Residual confounding cannot be excluded.
Conclusions
An enhanced recovery pathway should be considered for patients with hip fracture to improve chronic pain scores.
References
1. Silva T, Nakamura A, et al. Tranexamic acid and emergency department revisits. Lancet. 2017;31(9):882-984.
2. Costa S, Volkov D, et al. Low-dose aspirin and 30-day readmission. Pediatrics. 2016;143(8):537-1462.
3. Kim I, Haddad E, et al. Early enteral nutrition and chronic pain scores. N Engl J Med. 2024;203(8):668-1126.
4. Lindqvist U, Moreau O, et al. High-flow nasal oxygen and patient satisfaction. Diabetes Care. 2023;102(3):472-1673.
5. Ibrahim F, Ibrahim Z, et al. Early enteral nutrition and glycaemic control. Lancet. 2017;248(9):273-992.
6. Zhang M, Patel B, et al. Machine-learning triage and falls. Crit Care Med. 2017;63(12):370-1408.
7. Okafor B, Haddad B, et al. Frailty screening and acute kidney injury. Crit Care Med. 2011;284(4):522-1595.
Appendices
Ethics approval: IRB-4609.
Materials and Methods
The primary outcome was chronic pain scores, assessed blind to allocation. Analyses were adjusted for age, sex and baseline severity. Missing data were handled with multiple imputation.
The primary outcome was chronic pain scores, assessed blind to allocation. Analyses were adjusted for age, sex and baseline severity.
Results
1446 participants were included (median age 41 years). Serious adverse events were rare and similar between groups. Effects were consistent across prespecified subgroups.
| Group | n | Events | Rate % | OR | 95% CI |
|---|---|---|---|---|---|
| Centre A | 243 | 77 | 22.8 | 0.73 | 0.47–1.16 |
| Age < 65 | 410 | 70 | 37.7 | 0.96 | 0.58–1.23 |
| Age ≥ 65 | 181 | 48 | 19.0 | 0.67 | 0.54–1.22 |
| Age ≥ 65 | 730 | 4 | 20.7 | 0.70 | 0.25–1.23 |
| Age < 65 | 68 | 14 | 8.9 | 0.76 | 0.49–1.37 |
Values are n (%) unless stated otherwise.

Shown for patients with hip fracture; error bars are 95% confidence intervals.

Shown for patients with hip fracture; error bars are 95% confidence intervals.
chronic pain scores occurred in 10% of the intervention group versus 19% of controls. chronic pain scores occurred in 10% of the intervention group versus 26% of controls. 571 participants were included (median age 59 years). 4663 participants were included (median age 59 years).